Estrogen Replacement Therapy

"Estrogen Replacement Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.

Descriptor ID	D015914
MeSH Number(s)	E02.319.452.150
Concept/Terms	Estrogen Replacement Therapy Estrogen Replacement Therapy Estrogen Replacement Therapies Replacement Therapies, Estrogen Therapies, Estrogen Replacement Therapy, Estrogen Replacement Replacement Therapy, Estrogen Estrogen Replacement Estrogen Replacement Estrogen Replacements Replacements, Estrogen Replacement, Estrogen Postmenopausal Hormone Replacement Therapy Postmenopausal Hormone Replacement Therapy Hormone Replacement Therapy, Post-Menopausal Hormone Replacement Therapy, Post Menopausal Estrogen Progestin Replacement Therapy Estrogen Progestin Replacement Therapy Estrogen Progestin Combination Therapy

Below are MeSH descriptors whose meaning is more general than "Estrogen Replacement Therapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Hormone Replacement Therapy [E02.319.452]
Estrogen Replacement Therapy [E02.319.452.150]

Below are MeSH descriptors whose meaning is related to "Estrogen Replacement Therapy".

Below are MeSH descriptors whose meaning is more specific than "Estrogen Replacement Therapy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or minor topic of these publications.

Bar chart showing 83 publications over 25 distinct years, with a maximum of 9 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	0	1	1
1994	1	1	2
1998	1	0	1
1999	2	1	3
2000	3	2	5
2001	2	1	3
2002	4	2	6
2003	6	1	7
2004	2	2	4
2005	6	0	6
2006	6	3	9
2007	1	3	4
2008	2	0	2
2009	4	0	4
2010	2	1	3
2011	3	1	4
2012	2	2	4
2013	1	2	3
2014	1	0	1
2015	1	2	3
2016	1	0	1
2018	1	2	3
2019	0	1	1
2020	0	2	2
2021	0	1	1

Below are the most recent publications written about "Estrogen Replacement Therapy" by people in Profiles.

Reeves KW, Vieyra G, Grimes NP, Meliker J, Jackson RD, Wactawski-Wende J, Wallace R, Zoeller RT, Bigelow C, Hankinson SE, Manson JE, Cauley JA, Calafat AM. Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women. J Clin Endocrinol Metab. 2021 06 16; 106(7):e2567-e2579.

View in: PubMed
Haring B, Liu J, Rapp SR, Shimbo D, Padula CB, Mozhui K, Li W, Espeland M, Wassertheil-Smoller S. Heart Rate, Brain Imaging Biomarkers and Cognitive Impairment in Older (?63 years) Women. Am J Cardiol. 2020 08 15; 129:102-108.

View in: PubMed
Ding J. Clear vision in postmenopausal women: role of hormone therapy and diabetes. Menopause. 2020 03; 27(3):253-254.

View in: PubMed
Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, Brunner EJ, Kuh D, Hardy R, Avis NE, Gold EB, Derby CA, Matthews KA, Cade JE, Greenwood DC, Demakakos P, Brown DE, Sievert LL, Anderson D, Hayashi K, Lee JS, Mizunuma H, Tillin T, Simonsen MK, Adami HO, Weiderpass E, Mishra GD. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019 11; 4(11):e553-e564.

View in: PubMed
Crawford SL, Crandall CJ, Derby CA, El Khoudary SR, Waetjen LE, Fischer M, Joffe H. Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results. Menopause. 2018 12 21; 26(6):588-597.

View in: PubMed
Gass M, Larson J, Cochrane B, Manson JE, Lane D, Barnabei V, Ockene J, Stefanick ML, Mouton C. Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials. Menopause. 2018 03; 25(3):252-264.

View in: PubMed
Reeves KW, Pennell M, Foraker RE, Crandall CJ, Stefanick M, Paskett ED. Predictors of vasomotor symptoms among breast cancer survivors. J Cancer Surviv. 2018 06; 12(3):379-387.

View in: PubMed
Salmoirago-Blotcher E, Dunsiger S, Swales HH, Aurigemma GP, Ockene I, Rosman L, Wittstein IS. Reproductive History of Women With Takotsubo Cardiomyopathy. Am J Cardiol. 2016 Dec 15; 118(12):1922-1928.

View in: PubMed
Keaney JF, Solomon CG. Postmenopausal Hormone Therapy and Atherosclerosis--Time Is of the Essence. N Engl J Med. 2016 Mar 31; 374(13):1279-80.

View in: PubMed
Crandall CJ, Hovey KM, Andrews CA, Cauley JA, Manson JE, Wactawski-Wende J, Wright NC, Li W, Beavers K, Curtis JR, LeBoff MS. Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative Study. J Clin Endocrinol Metab. 2015 Nov; 100(11):4315-24.

View in: PubMed

People

Explore

Similar Concepts

Top Journals